We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Authors reply: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%.
- Authors
Parkin, Lianne; Williams, Sheila; Sharples, Katrina; Barson, David; Horsburgh, Simon; Jackson, Rod; Wu, Billy; Dummer, Jack
- Abstract
In addition, in an earlier national study we examined treatment patterns among patients with mild/moderate COPD severity at cohort entry whose first long-acting bronchodilator therapy was either a LAMA or a LABA [3]. Authors reply: Dual versus single long-acting bronchodilator use could raise acute coronary syndrome risk by over 50% Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?.
- Subjects
ACUTE coronary syndrome; MYOCARDIAL infarction; TRANSIENT ischemic attack; LONG-acting reversible contraceptives
- Publication
Journal of Internal Medicine, 2022, Vol 291, Issue 5, p707
- ISSN
0954-6820
- Publication type
Article
- DOI
10.1111/joim.13439